|
⚲
|
| Keyboard |
| James Andrea S
✚
|
|
|---|---|
| CIK # | 0002027010 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002027010] | |
| 4 | [0002027010] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| James Andrea S | |
| Oncocyte Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Oncocyte Corp IMDX
Restricted Stock Units · derivative
|
2026-03-26 | Option exercise | 28,302 | $0.00 | |
|
Oncocyte Corp IMDX
Common Stock
|
2026-03-26 | Tax withheld | 11,298 | $4.11 | 46,435 |
|
Oncocyte Corp IMDX
Common Stock
|
2026-03-26 | Option exercise | 28,302 | ||
|
Oncocyte Corp IMDX
Common Stock
|
2025-10-31 | Option exercise | 50,000 | $0.00 | |
|
Oncocyte Corp IMDX
Restricted Stock Units · derivative
|
2025-10-31 | Disposed to issuer | 50,000 | $0.00 | |
|
Oncocyte Corp OCX
Restricted Stock Units · derivative
|
2025-03-26 | Grant | 113,207 | $0.00 | |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2025-02-07 | Buy | 97,561 | $2.05 | 200,000 |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2024-12-05 | Buy | 20,000 | $2.29 | 45,800 |
|
Oncocyte Corp OCX
Restricted Stock Units · derivative
|
2024-10-11 | Grant | 100,000 | $0.00 | |
|
Oncocyte Corp OCX
Options to Purchase Common Stock · derivative
|
2024-10-11 | Grant | 200,000 | $0.00 | |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2024-10-02 | Buy | 33,670 | $2.97 | 100,000 |
|
Oncocyte Corp OCX
Restricted Stock Units · derivative
|
2024-06-20 | Grant | 100,000 | $0.00 | |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2024-06-20 | Grant | 200,000 | $0.00 |